...
首页> 外文期刊>RSC Advances >Preparative separation of mangiferin glycosides by high speed counter current chromatography and comparison of their antioxidant and antitumor activities
【24h】

Preparative separation of mangiferin glycosides by high speed counter current chromatography and comparison of their antioxidant and antitumor activities

机译:高速计数器电流色谱法制率糖苷的制备分离及其抗氧化剂和抗肿瘤活性的比较

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mangiferin, a xanthonoid with various bioactivities. The low solubility of mangiferin limits the use in pharmacological fields. In this study, high-speed counter-current chromatography (HSCCC) was used to separate and purify mangiferin glycosides from the crude sample after enzymatic glycosylation of mangiferin. Two fructosyl mangiferin were successfully purified by HSCCC with a two-phase-solvent system composed ofn-butanol-methanol-water (6 : 1 : 6, v/v). A total of 18 mg of mangiferin (I), 73 mg of beta-d-fructofuranosyl-(2 -> 6)-mangiferin (II), and 58 mg of beta-d-difructofuranosyl-(2 -> 6)-mangiferin (III) were obtained in one-step separation from 150 mg of the crude sample with purities of 99.2%, 98.7% and 98.9%, respectively. The chemical structures were identified by HRMS,H-1-NMR,C-13-NMR and 2D NMR. Mangiferin glycosides showed higher antioxidant and antitumor activities compared to that of mangiferin by employing DPPH scavenging effect, reducing power and cytotoxicity assay. Therefore, these novel fructosyl mangiferin exhibit a great potential to be developed into new medicines.
机译:Mangiferin,一种Xanthonoid,具有各种生物活跃。 Mangiferin的低溶解度限制了药物领域的用途。在该研究中,使用高速逆流色谱(HSCCC)在Mangiferin的酶促糖基化之后将Mangiferin糖苷与粗产物分离和纯化。通过HSCCC成功纯化了两个果糖甘草蛋白,其具有由对丁醇 - 甲醇 - 水(6:1:6,v / v)组成的两相溶剂体系。总共18毫克Mangiferin(I),73mgβ-d-果粥uranosyl-(2 - > 6)-Mangiferin(II)和58mgβ-D- Difructofuranylyl-(2 - > 6)-Mangiferin (iii)分别在150mg粗产物的一步分离中获得,纯度分别为99.2%,98.7%和98.9%。通过HRMS,H-1-NMR,C-13-NMR和2D NMR鉴定化学结构。通过使用DPPH清除效应,降低功率和细胞毒性测定,Mangiferin糖苷与Mangiferin相比显示出更高的抗氧化剂和抗肿瘤活性。因此,这些新颖的果糖Mangiferin表现出巨大的潜力将开发成新药物。

著录项

  • 来源
    《RSC Advances》 |2020年第43期|共6页
  • 作者

    Xu Tingting; Wu Xueming;

  • 作者单位

    Nanjing Univ Chinese Med Sch Med &

    Holist Integrat Med Nanjing 210023 Peoples R China;

    Nanjing Univ Chinese Med Sch Pharm Nanjing 210023 Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号